Showing results (331-340 of 447) with videos related to
Sort By:
Pageof 45
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2019
CD45+CD326+ Cells are Predictive of Poor Prognosis in Non-Small Cell Lung Cancer PatientsKota Ishizawa, Mie Yamanaka, Yuriko Saiki, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 4, 2016
PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison ProjectFred R Hirsch, Abigail McElhinny, Dave Stanforth, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|February 13, 2013
Primary esophageal and gastro-esophageal junction cancer xenograft models: clinicopathological features and engraftmentLorin Dodbiba, Jennifer Teichman, Andrew Fleet, et al.Clinical Lung Cancer|November 12, 2018
LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non-small-cell Lung CancerLesley Seymour, Gwénaël Le Teuff, Elisabeth Brambilla, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2018
Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung CancerSiddhartha Devarakonda, Federico Rotolo, Ming-Sound Tsao, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 21, 2015
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 ClassificationWilliam D Travis, Elisabeth Brambilla, Andrew G Nicholson, et al.Plos Computational Biology|January 11, 2019
Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancerDeena M A Gendoo, Robert E Denroche, Amy Zhang, et al.Plos Medicine|July 30, 2010
Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinomaWilliam W Lockwood, Raj Chari, Bradley P Coe, et al.Plos One|May 26, 2012
Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor developmentWilliam W Lockwood, Ian M Wilson, Bradley P Coe, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2020
Generation of Genetically Engineered Mouse Lung Organoid Models for Squamous Cell Lung Cancers Allows for the Study of Combinatorial ImmunotherapyJosephine Hai, Hua Zhang, Jin Zhou, et al.Pageof 45